Insiders Cingulate Inc.

Equities

CING

US17248W2044

Market Closed - Nasdaq Other stock markets 01:30:00 27/06/2024 am IST			5-day change	1st Jan Change
0.564 ^USD	-3.75%		-1.05%	-92.63%

21/05	FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD	CI
08/05	Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to Its Board of Directors	13/02	CI
Cingulate Inc. Appoints Jennifer L. Callahan as Senior Vice President	29/01	CI
Cingulate Inc. and Cingulate Therapeutics LLC Announce Resignation of Officer	15/12	CI
Shane Schaffer to Serve as Principal Financial Officer of Cingulate Inc	15/12	CI
Scott Applebaum Provides Cingulate Inc. with Notice of His Resignation from the Board of Directors	13/12	CI
Insider Buy: Cingulate	15/23/15	MT
Cingulate Inc. Announces Resignation of Jeff Conroy from the Board of Directors	09/23/09	CI
Cingulate Inc. Announces the Resignation of Jeff Hargroves from the Board of Directors	30/22/30	CI
Cingulate Inc. Appoints Scott Applebaum as Class III Director	11/22/11	CI
Cingulate Appoints Curt Medeiros and Gregg Givens to Board of Directors	25/22/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer